Rajiv Ranjit Nair

This paper demonstrates that using affinity cocktails of antibody-radioconjugates improves tumor irradiation by combining high- and low-affinity variants to target different tumor regions, leading to better treatment outcomes.

This study shows that systemic actinium-225 dendrimer-radioconjugates improve glioblastoma survival in mice, with enhanced efficacy when combined with temozolomide.

This study demonstrates that using two separate carriers for alpha-particle therapy improves tumor growth inhibition and survival in cancers with low target marker expression, without increasing radioactivity.